| Literature DB >> 34704321 |
Jennifer Pett1,2, Fahim Mohamed3,4,5,6, John Knight1,2, Christine Linhart1, Nicholas J Osborne1,7, Richard Taylor1.
Abstract
BACKGROUND: Chronic Kidney Disease of unknown origin (CKDu) excludes known primary renal conditions or systemic disease (such as diabetes mellitus or hypertension). Prominence of CKDu has been noted for some decades in Sri Lanka, especially among men in particular rural areas, prompting many studies directed towards environmental causation. This article critically reviews relevant primary studies.Entities:
Keywords: Sri Lanka; chronic/epidemiology; enal insufficiency; environmental exposure/adverse effects; global health; interstitial; nephritis
Mesh:
Year: 2021 PMID: 34704321 PMCID: PMC9298898 DOI: 10.1111/nep.13989
Source DB: PubMed Journal: Nephrology (Carlton) ISSN: 1320-5358 Impact factor: 2.358
FIGURE 1Inclusion criteria for review
Definitions of CKD and CKDu by different organizations
| Reference | Criteria |
|---|---|
|
|
Duration over 3 months of: eGFR <60 ml/min/1.73 m2, AND/OR Albuminuria—with an albumin creatinine ratio (ACR) ≥30 mg/g AND/OR Urinary sediment abnormalities e.g. red blood cell casts in proliferative glomerulonephritis, white blood cell casts in pyelonephritis, oval fat bodies or fatty casts in diseases with proteinuria AND/OR Electrolyte abnormalities, e.g. renal tubular acidosis, renal potassium wasting and renal magnesium wasting AND/OR Pathological abnormalities detected by histology or inferred, e.g. glomerular diseases, vascular diseases, tubulointerstitial diseases AND/OR Structural abnormalities detected by imaging, e.g. polycystic kidneys AND/OR History of renal transplantation |
|
| Albumin‐creatinine ratio ≥30 mg/g with no history of glomerulonephritis, pyelonephritis, renal calculi or snake bite, not on treatment for diabetes, HbA1c <6.5%, blood pressure <140/90 mmHg if on treatment for hypertension or <160/100 mmHg if not on treatment for hypertension |
|
|
eGFR <60 ml/min/1.73 m2 using CKD‐EPI Equation OR albuminuria ≥30 mg/g creatinine OR proteinuria ≥150 mg/g creatinine
urine protein/creatinine ratio > 3000 mg/g creatinine diagnosed diabetes, on treatment for diabetes, or random capillary plasma glucose ≥200 mg/dl hypertension with untreated blood pressure > 160/100 mmHg, or on more than two antihypertensives previous acute kidney injury requiring dialysis age > 70 years
eGFR <60 ml/min/1.73m2 using CKD‐EPI Equation OR albuminuria ≥30 mg/g creatinine OR proteinuria ≥150 mg/g creatinine
diabetes, as evidenced by fasting glucose ≥126 mg/dl, 2‐h plasma glucose ≥200 mg/dl on oral glucose test, or HbA1c ≥6.5% Clinical, laboratory or ultrasound evidence of other known causes of CKD including polycystic kidney disease, congenital malformations, autoimmune disease, glomerular diseases, obstructive nephropathy, kidney stones and, unequal kidney sizes of greater than >1.5 cm
Histopathological features of CKDu on biopsy OR Meeting all of the suspected and probable CKDu criteria and renal biopsy not possible |
CKD and CKDu definitions utilized in the literature in Sri Lanka
| Definition of CKD/CKDu | Number of studies |
|---|---|
| Unclear or undefined | 14 |
| ACR/dipstick proteinuria/microalbuminuria | 13 |
| Biopsy proven CKD/CKDu | 9 |
| Use of multiple diagnostic criteria | 9 |
| eGFR | 7 |
| Serum creatinine | 5 |
| Self‐reported | 2 |
Summary of published research findings, limitations and scope for future research
| Study Types | Cross‐sectional ( | Case–Control ( | Case Series ( | Ecological/Environmental ( | Other ( |
|---|---|---|---|---|---|
| Methods | Prevalence of CKDu/CKD by area, and by individual putative risk factors | Comparison of selected cases of CKDu/CKD with non‐cases (controls) | Characteristics of cases of CKD/CKDu and acute renal injury, with follow‐up in some instances | Measures of environmental risk factors with comparisons to guidance levels (not toxicity) and/or between areas |
Qualitative study (1) Experimental studies in animals (2) |
| Findings |
Identifies NCP as high prevalence area. Suggestive evidence of CKDu in other provinces. Some high‐quality prevalence studies Examined: Farming, family history, drink well water, dehydration, pesticide spray, urinary glyphosate, tobacco | Examined family history, farming, work in heat, agrochemical, exposure, male, tobacco, drink well water, Ayurvedic medication, hantavirus antibodies, snake bite, As in hair/nails |
Renal histopathology: tubulo‐interstitial nephritis Acute kidney injury possible precursor to CKDu. Some data on disease progression and mortality | Analyses of water, food and soil for Cd, As, Pb, & other heavy metals, plus trace elements to compare to guidance levels (not toxicity) from Sri Lankan and WHO advice |
Qualitative research offers perception of CKDu risk factors Experimental studies relate contaminated water source to CKD in rats |
|
Consistent evidence of influence of distal risk factors including rural residence, male sex and farming Identification of possible proximate/intermediate risk factors such as water source, agrochemicals, ayurverdic medication Lack of evidence for proximate causes e.g., environmental heavy metal contamination of water, soil or food | |||||
| Limitations of current research |
Measures prevalence not incidence Lack of quality research in various provinces limit comparisons of prevalence and localized risk factors |
Cases often not matched on demographic variables Cases and controls often hospital recruited |
No comparison to non‐cases Biopsies unable to demonstrate causative agent |
Environmental samples assessed without explicit linkage to CKDu prevalence Possible issues with instrument calibration or timing of sample collection |
Perception of risk factors may not relate to actual risk Animal studies may not relate to risk in humans |
|
Inconsistent definitions of CKD and CKDu and failure to distinguish between the two conditions Prevalent cases with uncertain period of exposure Inconsistent and/or undefined measures of exposure factors e.g. drinking water sources, agrochemical exposure Limitations of ability to relate exposures over time to CKDu diagnosis Non‐random recruitment of participants in many studies Difficulties in capture of historical exposure, e.g., changing water sources and agrochemicals use over time Often only one measurement of renal function for inclusion as acute or chronic kidney disease | |||||
| Suggestions for future research |
Random recruitment of participants High quality prevalence surveys to be conducted in all areas |
Random community‐based recruitment Cases and controls matched on demographic variables Measurement and comparison of further potential exposures, e.g., agrochemical levels in blood | Detailed case history interviews may provide further details on potential novel exposures for investigation | Linkage of population level data on CKDu prevalence to environmental samples in surveys of different high and low risk areas | Further qualitative research to identify novel risk factors for investigation by visits to high and low CKDu prevalence areas |
|
Usage of consistent and accepted definition of CKDu that is distinguished from CKD Improved and consistent definition of measured exposure factors such as agrochemical exposure, different types of farming and water sources Investigation of exposures that have been less well investigated, e.g., Ayurvedic medication Repeated measurement of renal function (e.g., 3 months apart) to ensure that disease is chronic Cohort studies ≥2 years would establish incidence and prevalence, and exposure measurement prior to clinical presentations, from periodic routine testing of the cohort for acute kidney injury AKIu and CKDu | |||||
If more than one study was published within the same article, each study was counted and reviewed separately for the purposes of critiquing the studies.